This inventor holds 2 USPTO granted patents. Top assignees: Medcom Advance, S.a., Medcom Tech, S.a., Fundacio Eurecat. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2021-2026
Title: Sara Gomez De Pedro: Innovator in Tumor Cell Detection
Introduction
Sara Gomez De Pedro is a prominent inventor based in Tarragona, Spain. She has made significant contributions to the field of medical technology, particularly in the detection of tumor cells. Her innovative work focuses on improving the accuracy and efficiency of liquid biopsies, which are crucial for cancer diagnosis and treatment.
Latest Patents
Sara holds a patent for an "Apparatus and method for detection of tumour cells and circulating tumour cells." This invention relates to a method of detecting and quantifying the number of circulating tumor cells (CTCs) and/or tumor cells (TCs) from a liquid biopsy. The process utilizes a hyperoxic environment and incubation with a fluorophore-labelled metabolic indicator, specifically a fluorophore-labelled 2-D-glucose derivative, along with microfluidic chips. This advancement has the potential to enhance cancer diagnostics significantly.
Career Highlights
Throughout her career, Sara has worked with notable companies such as Medcom Tech, S.A. and Fundación de Investigación HM Hospitales. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in medical technology.
Collaborations
Sara has collaborated with esteemed colleagues, including Juan Sagales and Carlos Villanueva Leal. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of cancer research.
Conclusion
Sara Gomez De Pedro is a trailblazer in the field of tumor cell detection, with her innovative patent paving the way for advancements in cancer diagnostics. Her contributions to medical technology are invaluable and continue to inspire future innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile